A Common Polymorphism in the MTHFD1 Gene Is a Modulator of Risk of Congenital Heart Disease

Several environmental and genetic factors may influence the risk of congenital heart defects (CHDs), which can have a substantial impact on pediatric morbidity and mortality. We investigated the association of polymorphisms in the genes of the folate and methionine pathways with CHDs using different strategies: a case-control, mother-child pair design, and a family-based association study. The polymorphism rs2236225 in the MTHFD1 was confirmed as an important modulator of CHD risk in both, whereas polymorphisms in MTRR, FPGS, and SLC19A1 were identified as risk factors in only one of the models. A strong synergistic effect on the development of CHDs was detected for MTHFD1 polymorphism and a lack of maternal folate supplementation during early pregnancy. A common polymorphism in the MTHFD1 is a genetic risk factor for the development of CHD, especially in the absence of folate supplementation in early pregnancy.

Automated summary

This study investigated the association between polymorphisms in the genes of the folate and methionine pathways and the risk of congenital heart defects (CHDs). The rs2236225 polymorphism in the MTHFD1 gene was confirmed as an important modulator of CHD risk, while polymorphisms in the MTRR, FPGS, and SLC19A1 genes were identified as risk factors in only one of the models. Furthermore, a strong synergistic effect was found between the MTHFD1 polymorphism and a lack of maternal folate supplementation during early pregnancy.